Amit Munshi

Amit Munshi is recorded as CEO at Pfizer Inc (PFE), Board Member at Zura Bio Ltd (ZURA) since June 17, 2026, Chairman at Zura Bio Ltd (ZURA), Chairman at Inhibikase Therapeutics, Inc. (IKT) since February 14, 2025 and Board Member at Inhibikase Therapeutics, Inc. (IKT). The newest filing on record that lists Amit Munshi as Chairman at Zura Bio Ltd (ZURA) is dated April 30, 2026. The newest filing on record that lists Amit Munshi as Board Member at Inhibikase Therapeutics, Inc. (IKT) is dated April 30, 2026. Zura Bio Ltd reported in an 8-K filed June 18, 2026 that Amit Munshi was appointed Director, effective June 17, 2026. Inhibikase Therapeutics, Inc. reported in an 8-K filed February 18, 2025 that Amit Munshi was appointed independent Chair of the Board, effective February 14, 2025. Inhibikase Therapeutics, Inc. reported in an 8-K filed October 22, 2024 that Amit Munshi was appointed Class II director of the Board, effective October 21, 2024. Equibles holds 6 filed executive changes naming Amit Munshi; each is listed under recent activity with its source filing. Inhibikase Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Pfizer Inc is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Inhibikase Therapeutics, Inc. includes Mark Iwicki (CEO and Board Member), Roberto Bellini (Chairman and Board Member), David McIntyre (CFO) and 4 others.